Dr. Timothy Sterling, MD

• Infectious Disease Medicine

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Southwest College Of Naturopathic Medicinehealth Sciences

  Medical School, 1990

• Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response, 2023-01-12

• Comparing Results from Multiple Imputation and Dynamic Marginal Structural Models for Estimating When to Start Antiretroviral Therapy, 2016-06-06

• Retention Among North American HIV-infected Persons in Clinical Care, 2000-2008, 2013-03-01

• A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts, 2016-04-04

• A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction, 2023-05-12

• Race and Sex Differences in Antiretroviral Therapy Use and Mortality among HIV-Infected Persons in Care, 2009-04-01

• Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada, 2013-12-18

• Black race, sex, and extrapulmonary tuberculosis risk: an observational study, 2010-01-22

• Pharmacokinetics and drug-drug interactions of isoniazid and efavirenz in pregnant women living with HIV in high TB incidence settings: importance of genotyping., 2020-10-16

• Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women, 2019-10-03

• Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy, 2022-02-01

• Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors, 2022-06-26

• Diagnostic biomarkers for active tuberculosis: progress and challenges, 2022-10-31

• Virologic, Immunologic and Clinical Responses in Foreign-Born versus US-Born HIV-1 Infected Adults Initiating Antiretroviral Therapy: An Observational Cohort Study, 2012-12-19

• Chronic kidney disease at presentation is not an independent risk factor for AIDS-defining events or death in HIV-infected persons, 2012-12-27

• Mood disorders and increased risk of non-communicable disease in adults with HIV, 2020-04-01

• Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis, 2018-08-14

• Increased Frequency of Memory CD4+ T-Cell Responses in Individuals With Previously Treated Extrapulmonary Tuberculosis, 2020-12-17

• Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection Mehaffy et al., 2020-05-26

• Development and Validation of a Model for Prediction of End-Stage Liver Disease in People with HIV, 2022-04-01

• Association between U.S. State AIDS Drug Assistance Program (ADAP) Features and HIV Antiretroviral Therapy Initiation, 2001-2009, 2013-11-18

• Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients, 2019-09-01

• Weight gain among treatment-naive persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada, 2020-04-15

• Treatment of drug-susceptible tuberculosis among people living with human immunodeficiency virus infection: an update, 2019-02-15

• Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada, 2017-08-01

• Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study, 2019-09-11

• Mortality among people entering HIV care compared to the general US population: an observational study, 2021-07-06

• Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens, 2017-12-15

• An internationally generalizable risk index for mortality after one year of antiretroviral therapy, 2013-02-20

• Duration of Exposure Among Close Contacts of Patients With Infectious Tuberculosis and Risk of Latent Tuberculosis Infection, 2020-10-23

• Trends in Multidrug Treatment Failure and Subsequent Mortality among Antiretroviral Therapy-Experienced Patients with HIV Infection in North America, 2009-11-15

• Chronic kidney disease at presentation is not an independent risk factor for AIDS-defining events or death in HIV-infected persons, 2013-07-22

• Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies, 2020-06-09

• Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy, 2022-04-05

• Increased vitamin D receptor expression from macrophages after stimulation withM. tuberculosisamong persons who have recovered from extrapulmonary tuberculosis, 2019-04-30

• Risk of Hepatocellular Carcinoma with Hepatitis B Viremia among HIV/Hepatitis B Virus-Coinfected Persons in North America, 2021-06-22

• The contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the US and Canada: A collaboration of cohort studies, 2019-01-22

• Duration of Anti-Tuberculosis Therapy and Timing of Antiretroviral Therapy Initiation: Association with Mortality in HIV-Related Tuberculosis, 2013-09-16

• Secular Trends in Breast Cancer Risk among Women with HIV Initiating ART in North America, 2021-05-01

• ODELAM, rapid sequence-independent detection of drug resistance in isolates ofMycobacterium tuberculosis, 2020-05-13

• CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?, 2010-12-15

• Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries, 2019-12-08

• Self-reported Cannabis Use and Changes in Body Mass Index, CD4 T-cell Counts, and HIV-1 RNA Suppression in Treated Persons with HIV, 2019-02-18

• Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report, 2014-09-18

• Exposure to Latent Tuberculosis Treatment during Pregnancy The PREVENT TB and the iAdhere Trials, 2019-07-03

• Diagnosis and treatment of latent tuberculosis infection: an update, 2014-05-03

• Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016, 2023-09-01

• Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the NA-ACCORD, 2021-11-23

• Predictive value of TNF-a, IFN-?, and IL-10 for tuberculosis among recently exposed contacts in the United States and Canada, 2020-07-31

• Cumulative Incidence of Cancer among HIV-infected Individuals in North America, 2015-10-06

• Risk Factors for Tuberculosis and Effect of Preventive Therapy Among Close Contacts of Persons With Infectious Tuberculosis, 2020-04-10

• Daily marijuana use is associated with missed clinic appointments among HIV-infected persons engaged in HIV care, 2017-03-17

• Tuberculosis and cardiovascular disease: linking the epidemics, 2015-10-30